Close menu




February 24th, 2023 | 15:55 CET

Nvidia, Meta Materials, Plug Power - Invest now in the mega markets of the future

  • metamaterials
  • Innovations
  • Technology
Photo credits: pixabay.com

The current economic and geopolitical situation can be frightening. But every era offers new opportunities. In addition to climate change, which is creating new industries with millions of new jobs, digitalization is booming, with artificial intelligence dominating everything. In addition, new materials are being developed whose properties can solve current challenges in industries such as semiconductors, AI, 5G, aerospace and automotive.

time to read: 4 minutes | Author: Stefan Feulner
ISIN: NVIDIA CORP. DL-_001 | US67066G1040 , Meta Materials Inc. | US59134N1046 , PLUG POWER INC. DL-_01 | US72919P2020

Table of contents:


    Meta Materials - Massive expansion of business areas

    The developer of sustainable, highly functional materials, Meta Materials, has a clear lead over its peer group. The Canadians, who want to redefine the future of coating materials, are researching novel materials that can redirect light, sound, heat and radio waves using special nanotechnology. The technology has multiple applications and can be used worldwide in industries such as 5G communications, health and wellness, aerospace, automotive and renewable energy. Meta Materials has a significant competitive edge with 410 active patent documents, including 251 issued patents and 159 pending patent applications.

    In order to further expand its businesses, the Company announced a USD 100 million capital increase. The proceeds will be used to develop Meta's product portfolio, including NANOWEB, Vlepsis, ARfusion and KolourOptik. In addition, the proceeds will be used for working capital, capital equipment purchases and general and administrative expenses.

    In addition to the offering, Meta Materials also released unaudited fourth-quarter figures. Consolidated revenue for the final quarter was USD 1.4 million, and full-year revenue was USD 10.2 million. The loss for the fourth quarter ranged from USD 21 million to USD 30 million. Thus, for the full year 2022, losses ran between USD 91 million and USD 100 million. At year-end, Meta Materials still had cash and short-term investments of USD 11.8 million.

    A contract for authentication and nano-optics security business with a maximum value of USD 41.5 million over a period of up to 5 years was secured with a G10 central bank customer. "Meta is developing a globally unique metamaterial nano-optical technology and anti-counterfeiting feature for our G10 central bank customer," said George Palikaras, president and CEO. "We are pleased to make progress on this prestigious and important contract with Meta Materials, the largest in the history of banknote security feature development." The global launch of its unique KolourOptik metamaterial nano-optical technology, which combines multi-directional motion, 3D stereo depth, high resolution and multiple colors, is planned for this year.

    Nvidia - Forecasts exceeded

    Positive signs came from leading graphics card maker Nvidia. The chip company was able to publish both revenue and profit above analysts' estimates. In the final quarter of fiscal 2023, which ended in late January, Nvidia posted revenue of USD 6.05 billion, up from USD 7.64 billion in the year-ago period. Profit was USD 1.41 billion, down from USD 3 billion at the end of 2021. For the first quarter of the current fiscal year 2024, the US giant expects revenues of around USD 6.5 billion.

    Positive voices came from several analyst firms following the release. Especially in the boom topic of artificial intelligence, Nvidia Corp. is expected to emerge as the biggest winner among chipmakers after years of focusing on this technology made the Company a preferred supplier for tech companies. The key to the Company's success is that it controls about 80% of the graphics processor market. These specialized chips provide the computing power needed for services like OpenAI's Microsoft-backed chatbot ChatGPT.

    Analysts at US analyst firm Bernstein Research raised their price target from USD 200 to USD 265 on the back of solid quarterly results and an outlook well above market expectations. The buy rating remains "outperform".

    Plug Power - Week of truth

    It will be exciting on Monday next week when the hydrogen specialist opens its books for the fourth quarter and the full year 2022. There were plenty of warnings in the run-up. In the third quarter, for example, sales targets were already cut to USD 845 million. At a strategy update in late January, CEO Andy Marsh warned again that the final quarter would likely be revised downward due to delayed product launches that impact the supply chain. Analysts are projecting revenue in the USD 766 million range, with a loss per share of USD 1.05.

    Next year, however, Plug Power has predicted in the past everything is supposed to get better. For example, the new product units that have fallen behind schedule are to be included in the figures. For the current fiscal year, the US company expects sales of USD 1.4 billion with a gross margin of 10%; in 2026, the forecast is already USD 5 billion with a gross margin of 30%. The CEO's statement on profitability is important. For example, Plug Power is reaching the break-even point expected in 2024 with quarterly sales of USD 600 million and a gross margin of 20%.

    Thus, with the current burn rate, another capital increase and dilution could be on the horizon. As of the end of September 2022, the cash position amounted to USD 1.75 billion. That means that in the first 9 months of last year, it fell by a whopping USD 1.2 billion. From a chart perspective, the 50-day line has just been breached to the downside. The next price target would be the support zone, currently at around EUR 11.


    Nividia was able to convince analyst houses when publishing its annual figures. Plug Power will publish annual figures at the beginning of next week. Meta Materials intends to further push the expansion of its product portfolio.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Mario Hose on February 27th, 2026 | 07:05 CET

    Revolution in cancer therapy: Vidac Pharma attacks the cancer throne of the big players! Why the smaller competitor could steal the show from giants like Bayer and BioNTech!

    • Cancer therapy
    • Cancer
    • bayer
    • vidac pharma
    • biontech
    • Innovations

    The world of biotechnology and pharmaceuticals is currently in turmoil, as technological breakthroughs and strategic realignments promise an exciting future for investors. The focus is particularly on Vidac Pharma, an innovative company that wants to revolutionize the fight against cancer with a completely new approach to oncology and is currently celebrating one milestone after another. While Vidac Pharma shines with impressive clinical progress and strong internal backing from its main shareholder, Dr. Max Herzberg, industry giant Bayer has recently struggled with the late effects of the Monsanto acquisition, but is now increasingly being touted as an exciting candidate for a split or takeover by financial investors. At the same time, BioNTech remains synonymous with cutting-edge mRNA technology, with the market eagerly awaiting the next phase after the pandemic. In this dynamic environment, Vidac Pharma is emerging as a particularly bright star in the biopharmaceutical sky, causing a sensation with its unique method of specifically normalizing the metabolism of cancer cells.

    Read

    Commented by Nico Popp on February 26th, 2026 | 07:40 CET

    From penny stock to tech pioneer: How Aspermont is transforming the commodity data market with Rio Tinto – Informa as a role model

    • data
    • Commodities
    • AI
    • Technology

    Data is the raw material for tomorrow's decisions. In an economy where algorithms and large language models (LLMs) rely on verified and structured information, access to high-quality archives determines competitiveness. Aspermont has recognized this need and is transforming itself from a traditional media company into a technology company in the field of data intelligence. With a cumulative brand archive covering over 200 years of mining history, the company has a comprehensive data set on the global commodities industry. With its Mining IQ platform, Aspermont is digitizing this historical knowledge and structuring it for AI applications. This realignment completes the company's fourth phase of technological development, which builds on 180 years of print publications and the digital media and content-as-a-service models. The quality of the data is ensured by more than 100 specialist journalists and analysts who provide qualitative input for the platform.

    Read

    Commented by Fabian Lorenz on February 26th, 2026 | 07:20 CET

    Drone stock with almost 100% price potential! Volatus Aerospace benefits from NATO's military buildup! Over CAD 600 million in the pipeline!

    • Drones
    • Defense
    • aerospace
    • Technology

    Drones are the future – both in military and civilian applications. Volatus Aerospace is benefiting from both segments. The company experienced a strong stock market run last year. And rightly so. The Canadian drone specialist serving military and civilian markets is profiting from increased defense spending in its home country and across NATO. For example, the company provides drone pilot training. Most recently, the Canadian government not only announced that it would invest billions in military buildup, but also unveiled a long-term strategy for the defense industry. This initiative is designed to provide companies with greater planning security. Several analysts have issued "Buy" recommendations for the stock, citing an order pipeline of more than CAD 600 million.

    Read